Lumida
/NUS
⌘K
NU Skin Enterprises Inc

NU Skin Enterprises Inc

NUS
$5.24USD-2.78%-0.15 today

MARKET CAP

254.4M

P/E (TTM)

4.4x

FWD P/E

4.3x

DAY RANGE

$5 – $5

52W RANGE

$5
$15

AI Summary

Stalk
Sell NowMedium

The asset is firmly in a Stage 4 decline with dominant lower highs and lower lows, down-trending moving averages, and persistent distribution. Medium-term bias is bearish, supported by structural downtrend and bearish pattern implications. Short-term price has attempted a bounce but was rejected at falling EMAs, indicating execution readiness for selling. The long-term secular trend remains negative. Risks include possible oversold mean-reversion bounces and a reclaim of EMAs that could signal a reversal.

  • Latin America Q2 revenue up 100% YoY shows emerging market strength
  • Prism IO platform launch expected to boost personalized wellness sales
  • North America growth stalled, signaling challenges in core market
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Nu Skin Enterprises, Inc. (NYSE: NUS) is a prominent global player in the beauty and wellness industry, focusing on skincare products and dietary supplements through a direct selling model. The company is strategically positioning itself to leverage technological advancements and expand its presence in emerging markets like India, viewing these territories as key growth opportunities. Nu Skin aims to capitalize on the burgeoning $6.8 trillion wellness market, enhancing its operational efficiency while navigating competitive pressures and macroeconomic challenges.

Bull says

  • Latin America Q2 revenue up 100% YoY shows emerging market strength
  • Prism IO platform launch expected to boost personalized wellness sales
  • Returned $8M via dividends and buybacks; cash of $264M maintains liquidity
  • Earnings yield at 2.74% and book-to-price of 1.16 suggest undervaluation
  • Over $20B in sales leader compensation drives affiliate engagement
  • High leverage factor could amplify returns if market conditions improve

Bear says

  • North America growth stalled, signaling challenges in core market
  • Operating margin down to 3.6%, underscoring weak profitability factors
  • Inflationary pressures strain consumers, potentially reducing premium product spending
  • Analyst downgrades reflect skepticism after negative revisions trend
  • Prism IO revenue impact unclear without formal guidance, raising rollout risk
  • Negative growth and profitability factors raise concerns over expansion viability

Investment themes with NUS

Others +0.32%

Miscellaneous or uncategorized companies

ATAI · SVIX · SVXY

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-11-2026bullish

Transcript signals

Bull points

  • And our next anticipated major market, India, holds tremendous potential in the future as we apply key learnings in this pre-market entry phase of operations to better understand the need of entrepreneurs and customers in the world's most populous market.
  • We're working to solidify our operations, infrastructure, and such ahead of our planned formal launch by the end of this year.
  • We're pleased with progress to date and are committed to continuing improvements in gross margin through localized manufacturing, portfolio optimization, and strategic pricing actions.

Bear points

  • General and administrative expenses declined by $9 million year-over-year on an adjusted basis, reflecting continued cost discipline while focusing on future investments. As a percentage of revenue, G&A was 29.9%, up from 28.9% in the prior year, reflecting our ongoing investments in technology and emerging market expansion, including India.
  • As a result, adjusted operating margin for the quarter was 3.6% down from 6.4% in the prior year.
Read full transcript analysis ›